UBS Group’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $411K | Buy |
107,253
+12,783
| +14% | +$49K | ﹤0.01% | 4991 |
|
|
2025
Q1 | $543K | Buy |
94,470
+195
| +0.2% | +$1.12K | ﹤0.01% | 4629 |
|
|
2024
Q4 | $470K | Buy |
94,275
+67,746
| +255% | +$338K | ﹤0.01% | 4739 |
|
|
2024
Q3 | $143K | Sell |
26,529
-21,497
| -45% | -$116K | ﹤0.01% | 4923 |
|
|
2024
Q2 | $159K | Sell |
48,026
-290
| -0.6% | -$960 | ﹤0.01% | 4703 |
|
|
2024
Q1 | $158K | Sell |
48,316
-4,761
| -9% | -$15.6K | ﹤0.01% | 4855 |
|
|
2023
Q4 | $186K | Sell |
53,077
-21,518
| -29% | -$75.5K | ﹤0.01% | 4637 |
|
|
2023
Q3 | $498K | Sell |
74,595
-14,634
| -16% | -$97.8K | ﹤0.01% | 3605 |
|
|
2023
Q2 | $749K | Buy |
89,229
+82,821
| +1,292% | +$695K | ﹤0.01% | 3518 |
|
|
2023
Q1 | $63.6K | Buy |
6,408
+4,608
| +256% | +$45.8K | ﹤0.01% | 5190 |
|
|
2022
Q4 | $12.5K | Sell |
1,800
-24,003
| -93% | -$167K | ﹤0.01% | 7068 |
|
|
2022
Q3 | $138K | Sell |
25,803
-734,694
| -97% | -$3.93M | ﹤0.01% | 4386 |
|
|
2022
Q2 | $3.04M | Sell |
760,497
-199,896
| -21% | -$798K | ﹤0.01% | 2108 |
|
|
2022
Q1 | $4.27M | Buy |
960,393
+776,593
| +423% | +$3.45M | ﹤0.01% | 2051 |
|
|
2021
Q4 | $735K | Buy |
183,800
+46,617
| +34% | +$186K | ﹤0.01% | 3682 |
|
|
2021
Q3 | $1.21M | Buy |
137,183
+122,307
| +822% | +$1.07M | ﹤0.01% | 3115 |
|
|
2021
Q2 | $168K | Sell |
14,876
-34,031
| -70% | -$384K | ﹤0.01% | 4460 |
|
|
2021
Q1 | $581K | Sell |
48,907
-53,473
| -52% | -$635K | ﹤0.01% | 3822 |
|
|
2020
Q4 | $702K | Sell |
102,380
-3,661
| -3% | -$25.1K | ﹤0.01% | 3413 |
|
|
2020
Q3 | $785K | Buy |
106,041
+102,823
| +3,195% | +$761K | ﹤0.01% | 3072 |
|
|
2020
Q2 | $14K | Sell |
3,218
-11,936
| -79% | -$51.9K | ﹤0.01% | 5927 |
|
|
2020
Q1 | $37K | Sell |
15,154
-26,517
| -64% | -$64.7K | ﹤0.01% | 5169 |
|
|
2019
Q4 | $242K | Buy |
41,671
+16,580
| +66% | +$96.3K | ﹤0.01% | 4472 |
|
|
2019
Q3 | $132K | Buy |
25,091
+15,815
| +170% | +$83.2K | ﹤0.01% | 4670 |
|
|
2019
Q2 | $56K | Sell |
9,276
-3,581
| -28% | -$21.6K | ﹤0.01% | 4958 |
|
|
2019
Q1 | $116K | Buy |
12,857
+140
| +1% | +$1.26K | ﹤0.01% | 4177 |
|
|
2018
Q4 | $106K | Buy |
12,717
+1,452
| +13% | +$12.1K | ﹤0.01% | 4611 |
|
|
2018
Q3 | $155K | Buy |
11,265
+4,109
| +57% | +$56.5K | ﹤0.01% | 4395 |
|
|
2018
Q2 | $57K | Buy |
7,156
+715
| +11% | +$5.7K | ﹤0.01% | 4983 |
|
|
2018
Q1 | $48K | Buy |
6,441
+4,516
| +235% | +$33.7K | ﹤0.01% | 4888 |
|
|
2017
Q4 | $13K | Buy |
1,925
+661
| +52% | +$4.46K | ﹤0.01% | 5880 |
|
|
2017
Q3 | $9K | Buy |
1,264
+156
| +14% | +$1.11K | ﹤0.01% | 6017 |
|
|
2017
Q2 | $5K | Sell |
1,108
-721
| -39% | -$3.25K | ﹤0.01% | 6151 |
|
|
2017
Q1 | $9K | Buy |
+1,829
| New | +$9K | ﹤0.01% | 5732 |
|
|
2016
Q2 | – | Sell |
-2,784
| Closed | -$12K | – | 6748 |
|
|
2016
Q1 | $12K | Buy |
2,784
+2,715
| +3,935% | +$11.7K | ﹤0.01% | 5689 |
|
|
2015
Q4 | $0 | Sell |
69
-1,520
| -96% | – | ﹤0.01% | 6834 |
|
|
2015
Q3 | $9K | Sell |
1,589
-333
| -17% | -$1.89K | ﹤0.01% | 5966 |
|
|
2015
Q2 | $15K | Buy |
1,922
+1,713
| +820% | +$13.4K | ﹤0.01% | 5706 |
|
|
2015
Q1 | $2K | Buy |
+209
| New | +$2K | ﹤0.01% | 6422 |
|